Researchers from Carnegie Mellon University have developed a novel way of labeling stem cells. Mesenchymal Stem Cells (MSCs) were engineered to uptake an iron-oxide nanoparticle called Ferumoxytol, which is picked up by means of magnetic resonance imaging (MRI). These developments allow researchers to assess cell migration and integration with a variety of tissues, aiding in clinical investigation of stem cell therapies.
StemSave Blog
Topics: stemsaveblog, stem cell therapies, clinical trials, nanoparticles, mesenchymal stem cells, autologous stem cells, magnetic resonance imaging, biolabel